(Q46146808)

19 December 2017

title

Guidelines for the diagnosis and treatment of vitiligo in Japan (English)

1 reference

19 December 2017

1 reference

Naoki Oiso

1

1 reference

19 December 2017

Tamio Suzuki

2

1 reference

19 December 2017

Mari Wataya-Kaneda

3

1 reference

19 December 2017

Atsushi Tanemura

4

1 reference

19 December 2017

Miki Tanioka

5

1 reference

19 December 2017

Tomoko Fujimoto

6

1 reference

19 December 2017

Kazuyoshi Fukai

7

1 reference

19 December 2017

Tamihiro Kawakami

8

1 reference

19 December 2017

Katsuhiko Tsukamoto

9

1 reference

19 December 2017

Yuji Yamaguchi

10

1 reference

19 December 2017

Shigetoshi Sano

11

1 reference

19 December 2017

Yoshihiko Mitsuhashi

12

1 reference

19 December 2017

Chikako Nishigori

13

1 reference

19 December 2017

Akimichi Morita

14

1 reference

19 December 2017

Hidemi Nakagawa

15

1 reference

19 December 2017

Masako Mizoguchi

16

1 reference

19 December 2017

Ichiro Katayama

17

1 reference

19 December 2017

publication date

27 February 2013

1 reference

19 December 2017

The Journal of Dermatology

published in

1 reference

19 December 2017

volume

40

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

344-354

1 reference

19 December 2017

Willingness-to-pay and quality of life in patients with vitiligo.

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Clinical practice. Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

HLA associations in vitiligo patients in the Dutch population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

NALP1 in vitiligo-associated multiple autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Identification of pigment cell antigens defined by vitiligo antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Melanocyte destruction and repopulation in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Epidermal oxidative stress in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Hypopigmentation in tinea versicolor: a histochemical and electronmicroscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Identification of Tyrosinase Inhibitors in Cultures of Pityrosporum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Guidelines for management of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

A double-blind trial of 0.05% clobetasol proprionate in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Guideline for the diagnosis and management of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Update on skin repigmentation therapies in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Establishment of suction blister roof grafting by injection of local anesthesia beneath the epidermis: less painful and more rapid formation of blisters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

Camouflage for patients with vitiligo vulgaris improved their quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12099

21 January 2018

Identifiers

DOI

10.1111/1346-8138.12099

1 reference

19 December 2017

1 reference

19 December 2017